Insider · CIK 0001205442

MCGRATH JOHN

Reports to the SEC for 3 companies · FREMONT, CA

sec.gov

Transactions

Companies

Filings

CIK

0001205442

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2018-03-20	ATRAAtara Biotherapeutics, Inc.S Sale	EVP & Chief Financial Officer	SSale	−3,000 sh	$38.83	−$116K	88,762
2018-03-19	ATRAAtara Biotherapeutics, Inc.S Sale	EVP & Chief Financial Officer	SSale	−3,000 sh	$41.99	−$126K	91,762
2018-02-16	ATRAAtara Biotherapeutics, Inc.S Sale	EVP & Chief Financial Officer	SSale	−4,000 sh	$46.93	−$188K	97,262
2018-02-16	ATRAAtara Biotherapeutics, Inc.S Sale	EVP & Chief Financial Officer	SSale	−2,500 sh	$48.08	−$120K	94,762
2018-02-15	ATRAAtara Biotherapeutics, Inc.M Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+5,132 sh	—	—	104,188
2018-02-15	ATRAAtara Biotherapeutics, Inc.S Sale	EVP & Chief Financial Officer	SSale	−6,500 sh	$46.77	−$304K	99,056
2018-02-15	ATRAAtara Biotherapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	−5,132 sh	—	—	0
2018-02-15	ATRAAtara Biotherapeutics, Inc.F Tax Payment	EVP & Chief Financial Officer	FTax Payment	−2,926 sh	$47.05	−$138K	101,262
2018-02-09	ATRAAtara Biotherapeutics, Inc.F Tax Payment	EVP & Chief Financial Officer	FTax Payment	−4,819 sh	$41.70	−$201K	105,556
2018-02-06	ATRAAtara Biotherapeutics, Inc.F Tax Payment	EVP & Chief Financial Officer	FTax Payment	−4,279 sh	$35.80	−$153K	110,375
2018-02-06	ATRAAtara Biotherapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	EVP & Chief Financial Officer	AAward	+50K sh	—	—	50,000
2018-02-06	ATRAAtara Biotherapeutics, Inc.A Award	EVP & Chief Financial Officer	AAward	+25K sh	—	—	114,654
2017-12-29	ATRAAtara Biotherapeutics, Inc.S Sale	EVP & Chief Financial Officer	SSale	−32K sh	$20.00	−$640K	96,654
2017-11-15	ATRAAtara Biotherapeutics, Inc.M Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+7,697 sh	—	—	128,654
2017-11-15	ATRAAtara Biotherapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	−7,697 sh	—	—	5,132
2017-08-16	ATRAAtara Biotherapeutics, Inc.S Sale	EVP & Chief Financial Officer	SSale	−2,100 sh	$14.39	−$30.2K	120,957
2017-08-15	ATRAAtara Biotherapeutics, Inc.S Sale	EVP & Chief Financial Officer	SSale	−2,100 sh	$14.23	−$29.9K	123,057
2017-08-15	ATRAAtara Biotherapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	−7,697 sh	—	—	12,829
2017-08-15	ATRAAtara Biotherapeutics, Inc.M Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+7,697 sh	—	—	125,157
2017-05-16	ATRAAtara Biotherapeutics, Inc.S Sale	EVP & Chief Financial Officer	SSale	−2,000 sh	$15.27	−$30.5K	117,460
2017-05-15	ATRAAtara Biotherapeutics, Inc.S Sale	EVP & Chief Financial Officer	SSale	−2,000 sh	$14.95	−$29.9K	119,460
2017-05-15	ATRAAtara Biotherapeutics, Inc.M Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+7,698 sh	—	—	121,460
2017-05-15	ATRAAtara Biotherapeutics, Inc.M Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+935 sh	—	—	113,762
2017-05-15	ATRAAtara Biotherapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	−7,698 sh	—	—	20,526
2017-05-15	ATRAAtara Biotherapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	−935 sh	—	—	0
2017-03-23	ATRAAtara Biotherapeutics, Inc.S Sale	EVP & Chief Financial Officer	SSale	−6,500 sh	$21.08	−$137K	112,827
2017-03-22	ATRAAtara Biotherapeutics, Inc.S Sale	EVP & Chief Financial Officer	SSale	−7,500 sh	$20.27	−$152K	119,327
2017-03-10	ATRAAtara Biotherapeutics, Inc.S Sale	EVP & Chief Financial Officer	SSale	−24K sh	$20.00	−$480K	126,827
2017-02-21	ATRAAtara Biotherapeutics, Inc.S Sale	EVP & Chief Financial Officer	SSale	−9,000 sh	$15.14	−$136K	150,827
2017-02-15	ATRAAtara Biotherapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	−7,697 sh	—	—	28,224
2017-02-15	ATRAAtara Biotherapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	−2,804 sh	—	—	935
2017-02-15	ATRAAtara Biotherapeutics, Inc.M Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+7,697 sh	—	—	159,827
2017-02-15	ATRAAtara Biotherapeutics, Inc.M Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+2,804 sh	—	—	152,130
2017-02-06	ATRAAtara Biotherapeutics, Inc.A Award	EVP & Chief Financial Officer	AAward	+49.5K sh	—	—	149,326
2016-11-15	ATRAAtara Biotherapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	−2,805 sh	—	—	3,739
2016-11-15	ATRAAtara Biotherapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	−7,698 sh	—	—	35,921
2016-11-15	ATRAAtara Biotherapeutics, Inc.M Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+2,805 sh	—	—	92,128
2016-11-15	ATRAAtara Biotherapeutics, Inc.M Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+7,698 sh	—	—	99,826
2016-11-11	ATRAAtara Biotherapeutics, Inc.S Sale	EVP & Chief Financial Officer	SSale	−2,500 sh	$19.37	−$48.4K	89,323
2016-11-10	ATRAAtara Biotherapeutics, Inc.S Sale	EVP & Chief Financial Officer	SSale	−2,500 sh	$20.30	−$50.8K	91,823
2016-10-12	ATRAAtara Biotherapeutics, Inc.S Sale	EVP & Chief Financial Officer	SSale	−2,500 sh	$16.41	−$41K	94,323
2016-10-11	ATRAAtara Biotherapeutics, Inc.S Sale	EVP & Chief Financial Officer	SSale	−2,500 sh	$18.52	−$46.3K	96,823
2016-08-15	ATRAAtara Biotherapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	−7,697 sh	—	—	43,619
2016-08-15	ATRAAtara Biotherapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	−2,804 sh	—	—	6,544
2016-08-15	ATRAAtara Biotherapeutics, Inc.M Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+7,697 sh	—	—	99,323
2016-08-15	ATRAAtara Biotherapeutics, Inc.M Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+2,804 sh	—	—	91,626
2016-05-16	ATRAAtara Biotherapeutics, Inc.M Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+7,698 sh	—	—	94,217
2016-05-16	ATRAAtara Biotherapeutics, Inc.M Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+2,805 sh	—	—	86,519
2016-05-16	ATRAAtara Biotherapeutics, Inc.S Sale	EVP & Chief Financial Officer	SSale	−5,395 sh	$15.77	−$85.1K	88,822
2016-05-16	ATRAAtara Biotherapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	−2,805 sh	—	—	9,348

Recent filings

Accepted (ET)
Mar 204
MCGRATH JOHN0001209191-18-020971
SEC(opens sec.gov)
Feb 204
MCGRATH JOHN0001209191-18-011664
SEC(opens sec.gov)
Feb 124
MCGRATH JOHN0001209191-18-009405
SEC(opens sec.gov)
Feb 84
MCGRATH JOHN0001209191-18-008508
SEC(opens sec.gov)
Jan 24
MCGRATH JOHN0001209191-18-000376
SEC(opens sec.gov)
Nov 174
MCGRATH JOHN0001209191-17-061602
SEC(opens sec.gov)
Aug 174
MCGRATH JOHN0001209191-17-049449
SEC(opens sec.gov)
May 174
Atara Biotherapeutics, Inc.0001209191-17-033208
SEC(opens sec.gov)

Companies

Address

6900 PASEO PADRE PARKWAY

FREMONT, CA, 94555